Jennifer Dien Bard

Jennifer Dien Bard

Auto-generated profile, based on publicly available information

Jennifer Dien Bard

Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2021 in EBioMedicine
Verified
Journal Article
Open access
TTThao T. Truong
Thao T. Truong
ARAlex Ryutov
Alex Ryutov
UPUtsav Pandey
Utsav Pandey
RYRebecca Yee
Rebecca Yee
LGLior Goldberg
Lior Goldberg
JBJennifer Dien Bard
Jennifer Dien Bard
There is increasing concern that persistent infection of SARS-CoV-2 within immunocompromised hosts could serve as a reservoir for mutation accumulation and subsequent emergence of novel strains with the potential to evade immune responses. We describe three patients with acute lymphoblastic leukemia who were persistently positive for SARS-CoV-2 by real-time polymerase chain reaction. Viral viability from longitudinally-collected specimens was assessed. Whole-genome sequencing and serological studies were performed to measure viral evolution and evidence of immune escape. We found compelling evidence of ongoing replication and infectivity for up to 162 days from initial positive by subgenomic RNA, single-stranded RNA, and viral culture analysis. Our results reveal a broad spectrum of infectivity, host immune responses, and accumulation of mutations, some with the potential for immune escape. Our results highlight the potential need to reassess infection control precautions in the management and care of immunocompromised patients. Routine surveillance of mutations and evaluation of their potential impact on viral transmission and immune escape should be considered.

19 May 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
RYRebecca Yee
Rebecca Yee
JBJennifer Dien Bard
Jennifer Dien Bard
PSPatricia J. Simner
Patricia J. Simner
Traditional culture-based methods for identification and antimicrobial susceptibility testing (AST) of bacteria take 2 to 3 days on average. Syndromic molecular diagnostic panels have revolutionized clinical microbiology laboratories as they can simultaneously identify an organism and detect some of the most significant antimicrobial resistance (AMR) genes directly from positive blood culture broth or from various specimen types (e.g., whole blood, cerebrospinal fluid, and respiratory specimens).

1 December 2020 in Clinics In Laboratory Medicine
Verified
Journal Article
Closed access
JBJennifer Dien Bard
Jennifer Dien Bard
EMErin McElvania
Erin McElvania

17 December 2020 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
PDF file
LKLarry K. Kociolek
Larry K. Kociolek
WMWilliam J. Muller
William J. Muller
RYRebecca Yee
Rebecca Yee
JBJennifer Dien Bard
Jennifer Dien Bard
CBCameron A. Brown
Cameron A. Brown
NPNira Pollock
Nira Pollock
The distribution of upper respiratory viral loads (VL) in asymptomatic children infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is unknown. We assessed PCR cycle threshold (Ct) values and estimated VL in infected asymptomatic children diagnosed in nine pediatric hospital testing programs. Records for asymptomatic and symptomatic patients with positive clinical SARS-CoV-2 tests were reviewed. Ct values were (i) adjusted by centering each value around the institutional median Ct value from symptomatic children tested with that assay and (ii) converted to estimated VL (numbers of copies per milliliter) using internal or manufacturer data. Adjusted Ct values and estimated VL for asymptomatic versus symptomatic children (118 asymptomatic versus 197 symptomatic children aged 0 to 4 years, 79 asymptomatic versus 97 symptomatic children aged 5 to 9 years, 69 asymptomatic versus 75 symptomatic children aged 10 to 13 years, 73 asymptomatic versus 109 symptomatic children aged 14 to 17 years) were compared. The median adjusted Ct value for asymptomatic children was 10.3 cycles higher than for symptomatic children (P < 0.0001), and VL were 3 to 4 logs lower than for symptomatic children (P < 0.0001); differences were consistent (P < 0.0001) across all four age brackets. These differences were consistent across all institutions and by sex, ethnicity, and race. Asymptomatic children with diabetes (odds ratio [OR], 6.5; P = 0.01), a recent contact (OR, 2.3; P = 0.02), and testing for surveillance (OR, 2.7; P = 0.005) had higher estimated risks of having a Ct value in the lowest quartile than children without, while an immunocompromised status had no effect. Children with asymptomatic SARS-CoV-2 infection had lower levels of virus in their nasopharynx/oropharynx than symptomatic children, but the timing of infection relative to diagnosis likely impacted levels in asymptomatic children. Caution is recommended when choosing diagnostic tests for screening of asymptomatic children.

1 June 2018 in Clinical Microbiology Newsletter
Verified
Journal Article
Closed access
JBJennifer Dien Bard
Jennifer Dien Bard
FLFrancesca Lee
Francesca Lee

21 January 2021 in Journal of Clinical Microbiology
Verified
Journal Article
Closed access
RYRebecca Yee
Rebecca Yee
TTThao T. Truong
Thao T. Truong
PPPia S. Pannaraj
Pia S. Pannaraj
NENatalie Eubanks
Natalie Eubanks
EGEmily Gai
Emily Gai
JBJennifer Dien Bard
Jennifer Dien Bard
Testing efforts for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been burdened by the scarcity of testing materials and personal protective equipment for health care workers. The simple and painless process of saliva collection allows for widespread testing, but enthusiasm is hampered by variable performance compared to that of nasopharyngeal swab (NPS) samples.